Cooper Financial Group Astrazeneca PLC Transaction History
Cooper Financial Group
- $866 Million
- Q3 2025
A detailed history of Cooper Financial Group transactions in Astrazeneca PLC stock. As of the latest transaction made, Cooper Financial Group holds 16,114 shares of AZN stock, worth $1.33 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
16,114
Previous 15,482
4.08%
Holding current value
$1.33 Million
Previous $1.08 Million
14.34%
% of portfolio
0.14%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,449Shares Held
489MCall Options Held
7.22MPut Options Held
2.57M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$4.28 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.39 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.83 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.59 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.57 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $255B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...